Most Recent Articles by Leah Lawrence
Scientific models project a continued decrease in lung cancer mortality.
Significant improvements were seen with the addition of atezolizumab to CnP in stage IV non-squamous non-small cell lung cancer, regardless of patient PD-L1 status.
Immune-Related Adverse Events Due to Checkpoint Inhibition Are More Common in Melanoma Than in NSCLCOct 19, 2018
Researchers investigated whether the rates of immune-related adverse events linked to treatment with nivolumab or pembrolizumab were similar across 2 different cancer types.
Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.
Few cases of lung cancer suspected in counties with smoke-free ordinances.